Veterinary Medicines

Benazecare Flavour 5 mg Tablets for Dogs and Cats

Authorised
This information is not available for this product.
Download as PDF

Product identification

Medicine name:
Benazecare Flavour 5 mg Tablets for Dogs and Cats
BENAZECARE Flavour 5 mg Tabletten für Hunde und Katzen
Active substance:
This information is not available for this product.
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA07
Legal status of supply:
  • Medicinal product on medical prescription for renewable delivery
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00725
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0452/001
Concerned member states:
  • Austria
  • Belgium
  • France
  • Germany
  • Luxembourg
  • Netherlands
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
German (PDF)
Published on: 21/02/2019
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 10/05/2023
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 10/05/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."